Up next
Does a Toddler Need an NFT?
The Biden administration on Tuesday is expected to outline plans to make it easier for infected people to get Covid-19 treatments, which some health leaders and patient advocates say are too difficult to obtain despite a federal program to help make them more widely available.
The administration has heavily touted vaccines to reduce the risk of serious illness from Covid-19. Officials also have been urging greater use of two pills given they are easy to take at home: Pfizer Inc.’s Paxlovid and Merck & Co.’s and Ridgeback Biotherapeutics LP’s molnupiravir, also known as Lagevrio. Both were cleared for use by the U.S. Food and Drug Administration in December.
To Read the Full Story
